HYL — Hyloris Pharmaceuticals SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Hyloris Pharmaceuticals SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	64.4	50.5	43.9	30.9	24.1
Net Total Accounts Receivable
Net Total Receivables	0.253	2.32	4.13	3.81	5.37
Prepaid Expenses
Total Current Assets	66.6	54	49.8	35.3	29.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.176	0.295	1.06	2.15	1.99
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	69.2	63.4	60.7	47.7	41.3
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.13	15	5.77	6.76	7.16
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.1	15.4	6.82	8.61	9.19
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59.1	48.1	53.9	39.1	32.1
Total Liabilities & Shareholders' Equity	69.2	63.4	60.7	47.7	41.3
Total Common Shares Outstanding